AUM Biosciences

Singapore, Singapore · Founded 2018 · Privately Held (backing)

Developer of an oncology-focused biotechnology platform designed to help in harnessing the power of digital and precision medicine. AUM Biosciences is based in Singapore, Singapore and was founded in 2018. Its last reported valuation was $98.7 million in Oct 2021. It has raised $29.7 million.

Last reported valuation

$98.7M

Oct 2026

Priced at

—

Total raised

$29.7M

Last round

—

How much has AUM Biosciences raised?

$29.7Macross 0 recorded rounds

Free account

More of AUM Biosciences with a free account

·Watch AUM Biosciences: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AUM Biosciences investors

9 investors are on record for AUM Biosciences, including SPRIM Global Investments, ASA Capital Partners, Accelerate Technologies and Agency for Science.

For fundraisers

Raising for a company like AUM Biosciences?

9 investors have backed AUM Biosciences.

See all 9 investors →

Frequently asked about AUM Biosciences

How much has AUM Biosciences raised?: AUM Biosciences has raised $29.7M in total across 0 recorded funding rounds.